Madaus GmbH (A Viatris Company)
Viatris: A Global Healthcare Company Serving Health
editOverview
editViatris is a US healthcare company based in Delaware that is dedicated to the mission of making it easier for people around the world to access high-quality medicines. In 2020, Viatris was formed through the merger of Mylan and Upjohn, a former Pfizer division[2][4]. The company is uniquely positioned in the area between generic and brand-name drugs to comprehensively meet the health needs of global populations.
Key Products and Services
editViatris offers an extensive portfolio of more than 1,200 drug forms, including Originals, Generics and Biosimilars. These range from prescription drugs to over-the-counter medications to Vaccines and complex drugs in Immunology and Oncology, as well as Antithrombotics[2][4]. In Germany, the company is responsible for approximately 4,500 individual doses per minute being dispensed in pharmacies every year[1].
Main Mission and Values
editViatris's main mission is to make people healthier throughout their lives by providing easy access to medicines. The company places great emphasis on sustainable corporate governance and innovative solutions to improve therapeutic outcomes[2]. With a global presence in more than 165 countries and more than 50 production facilities, Viatris ensures an efficient supply of high-quality medicines[5].
Sustainability and Social Responsibility
editViatris emphasizes the importance of sustainable business practices and is committed to initiatives that promote patient-centered solutions. In the area of social responsibility, the company is committed to social issues and is constantly working to use its global reach to meet unmet medical needs[3].
Current Developments
editViatris is actively involved in the research and development of new drugs and has recently made progress through positive Phase 3 studies and the submission of marketing authorization applications for new indications. In addition, the company is heavily involved in the education and development of opportunities for employees and partners[4].
